Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
909.9000
6.20
(
0.69
%)
NSE
Jun 29, 2026
13:18 PM
25.83% Fall from 52W High
Volume:
749.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
20 Aug 2024
909.90
0.69%
NATCO PHARMA
Accumulate:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 1597
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 254 to 285 in Mar 2026 qtr.
More from Natco Pharma Ltd.
Recommended
Market trades lower, DCX Systems secures orders worth Rs 436 crore
Trendlyne Marketwatch |
29 Jun 2026, 01:11PM
Five Interesting Stocks Today - June 26, 2026
The Baseline |
26 Jun 2026
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020